BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 11031209)

  • 1. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N
    Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
    Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
    Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis.
    Rouzaud-Laborde C; Delmas C; Pizzinat N; Tortosa F; Garcia C; Mialet-Perez J; Payrastre B; Sié P; Spreux-Varoquaux O; Sallerin B; Carrié D; Galinier M; Parini A; Lairez O
    Am J Hematol; 2015 Jan; 90(1):15-9. PubMed ID: 25242620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.
    Kazimierczyk R; Błaszczak P; Kowal K; Jasiewicz M; Knapp M; Szpakowicz A; Ptaszyńska-Kopczyńska K; Sobkowicz B; Waszkiewicz E; Grzywna R; Musial WJ; Kamiński KA
    Cytokine; 2018 Jul; 107():52-58. PubMed ID: 29203267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
    Friedman R; Mears JG; Barst RJ
    Circulation; 1997 Nov; 96(9):2782-4. PubMed ID: 9386137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma serotonin in primary pulmonary hypertension.
    Hervé P; Launay JM; Scrobohaci ML; Brenot F; Simonneau G; Petitpretz P; Poubeau P; Cerrina J; Duroux P; Drouet L
    Am J Med; 1995 Sep; 99(3):249-54. PubMed ID: 7653484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
    van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension.
    Ting H; Sun XG; Chuang ML; Lewis DA; Hansen JE; Wasserman K
    Chest; 2001 Mar; 119(3):824-32. PubMed ID: 11243964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil cathepsin G is a potent platelet activator.
    LaRosa CA; Rohrer MJ; Benoit SE; Rodino LJ; Barnard MR; Michelson AD
    J Vasc Surg; 1994 Feb; 19(2):306-18; discussion 318-9. PubMed ID: 7509416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
    Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
    Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epoprostenol on platelet activation and consumption during experimental extracorporeal perfusion.
    Skogby M; Adrian K; Friberg L; Mellgren K
    Artif Organs; 1999 Nov; 23(11):984-7. PubMed ID: 10564302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
    Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
    J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension.
    Katsushi H; Kazufumi N; Hideki F; Katsumasa M; Hiroshi M; Kengo K; Hiroshi D; Nobuyoshi S; Tetsuro E; Hiromi M; Tohru O
    Circ J; 2004 Mar; 68(3):227-31. PubMed ID: 14993777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.